CLGN vs CMMB: Side-by-Side Comparison
Compare CollPlant Biotechnologies Ltd New (CLGN) and Chemomab Therapeutics Ltd (CMMB) side by side: market cap USD 4.91M vs USD 16.34M. Financials, growth and model signals on Bullrun.
| Metric | CLGN | CMMB |
|---|---|---|
| Company | CollPlant Biotechnologies Ltd New | Chemomab Therapeutics Ltd |
| Country / Exchange | Israel · NASDAQ | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 4.91M | USD 16.34M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 2.37M | — |
| Revenue growth YoY | +360.4% | — |
| Net income | USD -11.49M | USD -9.00M |
| Gross margin | 64.8% | — |
| Diluted EPS | -0.94 | 0.02 |